Abstract:Objective To observe the prognosis situation of diabetic patients accepted percutaneous coronary intervention(PCI)and to evaluate the impact of diabetes mellitus on prognosis of PCI. Methods Data of 583 patients conducted PCI in department of cardiology in Dashiqiao Central Hospital of Liaolin Province from July 2012 to June 2014 were retrospectively analyzed.Patients were divided into DM group(n=152)and NDM (n=431)group by wether combined with diabetes mellitus or not.The main adverse cardiovascular events(MACE)incidence situation liked miocardial infarction and PCI operation again,coronary artery bypass surgery and death in after 1 year operation in two groups were recorded. Results 1 year mortality rate in DM group was 4.6%,and it was obviously higher than that of NDM group (0.7%)(P<0.01).Miocardial infarction rate again was 12.5%in DM group,and it was higher than that of NDM group (6.3%)(P<0.01).The incidence rate of total adverse cardiovascular event in DM group was 25.7%,and it was higher than that of NDM group(13.9%)(P<0.01). Conclusion The ratio of coronary heart disease patients with diabetes mellitus occurred MACE after PCI is higher.So,although patients are given successfully underwent PCI therapy,it still needs to attach importance to the further treatment of diabetes,and continuous pay attention to blood sugar and blood fat.
Grundy SM,Benjamin IJ,Burke GL,et al.Diabetes and cardiovascular disease:a statement for healthcare professionals from the American Heart Association [J].Circulation,1999,100(10):1134-1146.
[2]
Garg P,Normand SL,Silbaugh TS,et al.Drug-eluting or baremetal stenting in patients with diabetes mellitus:results from the Massachusetts Data Analysis Center Registry[J]. Circulation,2008,118(22):2277-2285.
[3]
Haffner SM,Lehto S,Ronnemaa T,et al.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J].N Engl J Med,1998,339(4):229-234.
[4]
Sprafka JM,Burke GL,Folsom AR,et al.Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival:the Minnesota Heart Survey[J].Diabetes Care,1991,14(7):537-543.
Sun N,Wang H,Sun Y,et al.Detecting diabetic risk using the oral glucose tolerance test in Chinese patients with hypertension:a cross-sectional study[J].Hypertens Res,2014,37(1):82-87.
[7]
Bartnik M,Malmberg K,Norhammar A,et al.Newly detected abnormal glucose tolerance:an important predictor of long-term outcome after myocardial infarction[J].Eur Heart J,2004,25(22):1990-1997.
[9]
Mehran R,Dangas GD,Kobayashi Y,et al.Short- and longterm results after multivessel stenting in diabetic patients[J]. J Am Coll Cardiol,2004,43(8):1348-1354.
[10]
Srikanth S,Deedwania P.Management of coronary artery disease in patients with type 2 diabetes mellitus[J].Curr Cardiol Rep,2007,9(4):264-271.
[11]
Moreno PR,Fuster V.New aspects in the pathogenesis of diabetic atherothrombosis[J].J Am Coll Cardiol,2004,44 (12):2293-2300.
[12]
Kornowski R,Mintz GS,Kent KM,et al.Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia:a serial intravascular ultrasound study[J].Circulation,1997,95(6):1366-1369.
[13]
Creager MA,Luscher TF,Cosentino F,et al.Diabetes and vascular disease:pathophysiology,clinical consequences,and medical therapy:PartⅠ[J].Circulation,2003,108 (9):1527-1532.
[15]
Holman RR,Paul SK,Bethel MA,et al.10-year followup of intensive glucose control in type 2 diabetes[J].N Engl J Med,2008,359(15):1577-1589.